Heart failure is a cardiovascular disease that affects more than 64 million people worldwide.
A study led by researchers at the University of Glasgow has found that the latest heart failure monitoring devices can be used to monitor patients and potentially help prevent hospital admissions.
Published in European Heart Failure Journal The CONGEST-HF study, presented at the European Society of Cardiology’s Heart Failure Congress, tested Analog Devices, Inc.’s (ADI) Sensinel cardiopulmonary management (CPM) system in 66 patients with cardiovascular disease.
Heart failure, which affects more than 64 million people worldwide, occurs when the heart is unable to pump enough blood around the body.
Most heart failure patients are hospitalized multiple times for treatment with intravenous diuretics, and current methods rely on expensive and invasive monitoring, including specially designed pacemakers and sensors implanted directly into the lungs. It depends.
The Sensinel CPM device is applied to the skin of a patient’s chest and measures physiological parameters and cardiopulmonary indicators such as heart sounds, heart rate, body temperature, and respiratory rate via Bluetooth to measure heart, lung, and other functions.
After testing the non-invasive device, researchers found that it could detect changes in body fluids in heart failure patients admitted to the hospital for decongestant therapy or hemodialysis to remove fluid.
The results showed that the device worked successfully and was able to detect changes in body fluids as well as body weight in patients who had body fluids removed.
Researchers believe that if worn for less than five minutes per day, the device could provide an alternative way to monitor heart failure patients and detect fluid overload, ultimately reducing costly hospitalization costs. That’s what I think.
Pardeep Jund, Professor of Cardiology and Epidemiology at the University of Glasgow, said: “This innovative system will take many important patient measurements and help identify fluid overload in the clinical setting. It is closely aligned with the metrics we rely on.”
The researchers aim to conduct a larger study to determine whether the device can detect fluid buildup in patients at home and provide enough warning to reduce hospital admissions.
